CONSTANT LEVERAGE SHORT - PFIZER INC Stock

Certificat

MS6IB

NLBNPNL245X9

Market Closed - Euronext Paris 12:30:02 2024-05-17 EDT
21.98 EUR +3.63% Intraday chart for CONSTANT LEVERAGE SHORT - PFIZER INC
Current month-53.15%
1 month-57.05%
Date Price Change
24-05-17 21.98 +3.63%
24-05-16 21.2 +1.97%
24-05-15 20.8 -11.98%
24-05-14 23.62 +1.24%
24-05-13 23.34 -5.68%

Real-time Euronext Paris

Last update May 17, 2024 at 12:30 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
MS6IB
ISINNLBNPNL245X9
Date issued 2022-10-26
Maturity Unlimited
Parity 1 : 1
Emission price 10
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 57.9
Lowest since issue 3.233
Spread 0.21
Spread %0.95%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.92 USD
Average target price
31.94 USD
Spread / Average Target
+10.44%
Consensus
  1. Stock Market
  2. Certificates
  3. MS6IB Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW